Navigere Competitors and Similar CompaniesClear all
Navigere's competitors and similar companies include Aspira Women's Health, Interpace Diagnostics, Higi and Anixa Biosciences.
 Navigere Navigere (formerly known as Spreemo Diagnostics) is a one-call company whose mission is to connect injured workers with diagnostics providers. |  Aspira Women's Health Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health. |  Interpace Diagnostics Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies. |  Higi Higi is a company that provides a self-screening health station network intended to facilitate self-diagnosis and health tracking. |  Anixa Biosciences Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers. | |
Founding Date | Founding Date 2012 | Founding Date 1993 | Founding Date 1987 | Founding Date 2012 | Founding Date 1982 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Dallas, US HQ | Locations Austin, US HQ | Locations Parsippany-Troy Hills, US HQ Morrisville, US Pittsburgh, US | Locations Chicago, US HQ Chicago, US | Locations San Jose, US HQ |
Employees | Employees N/A | Employees 4310% increase | Employees 8919% increase | Employees 72 | Employees 7 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 15.1 m | Valuation ($) 11.5 m | Valuation ($) N/A | Valuation ($) 127.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $343k (FY, 2025) | Revenue (est.) $38.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2025) | Cost of goods $14.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $5.9m (FY, 2025) | Gross profit $24.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($12.8m) (FY, 2025) | Net income $24.6m (FY, 2025) | Net income N/A | Net income ($11m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 84.4m | Total funding raised N/A | Total funding raised $ 91.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Aspira Women's Health
HQ
Austin, US
Employees
43↑ 10% increase
Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.
View companyInterpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
View companyHigi
HQ
Chicago, US
Employees
72
Higi is a company that provides a self-screening health station network intended to facilitate self-diagnosis and health tracking.
View companyAnixa Biosciences
HQ
San Jose, US
Employees
7
Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers.
View company